Coronary stent thrombosis: Difference between revisions

Jump to navigation Jump to search
mNo edit summary
 
(14 intermediate revisions by 4 users not shown)
Line 1: Line 1:
{{SI}}
__NOTOC__
{{WikiDoc Cardiology Network Infobox}}
{{Stent thrombosis}}
{{CMG}} ; '''Associate Editors-In-Chief:''' Smita Kohli, M.D.; [[ William J. Gibson]]; [[Varun Kumar]], M.B.B.S.; [[Lakshmi Gopalakrishnan]], M.B.B.S.


'''Editors-In-Chief:''' Allen Jeremias, M.D., SUNY; Don Cutlip, M.D. Beth Israel Deaconess Medical Center, Harvard
==[[Stent thrombosis introduction|Introduction]]==


'''Associate Editors-In-Chief:''' Priyantha Ranaweera, M.D.; William J. Gibson, MIT
==[[Stent thrombosis definition|Definition]]==
==Epidemiology and Demographics==
[[Stent thrombosis incidence in bare metal stents|Relation to Bare Metal Stents]] | [[Stent thrombosis Relation to drug eluting stents|Relation to Drug Eluting Stents]] | [[Stent thrombosis with antithrombotics|Relation to Antiplatelet Medications]]


{{Editor Help}}
==[[Stent thrombosis pathophysiology|Pathophysiology]]==
==[[Stent thrombosis risk factors|Risk Factors]]==


===[[Introduction]]===
==[[Stent thrombosis relationship to discontinuation of antiplatelet therapy|Relationship to Discontinuation of Antiplatelet Therapy]]==


===[[Definitions - coronary stent thombosis (ST)]]===
==[[Stent thrombosis treatment|Treatment]]==


==Incidence of coronary stent thrombosis (ST)==
==[[Stent thrombosis complications|Complications]]==
[[Incidence of coronary stent thrombosis (ST) in bare metal stents (BMS)|Relation to Bare Metal Stents]] | [[Incidence of coronary stent thrombosis (ST) in drug eluting stents (DES)|Relation to Drug Eluting Stents]] | [[Incidence of drug eluting stent thrombosis (ST) in relation to antiplatelet medication use|Relation to antiplatelet medications]]
 
===[[Mechanism and pathophysiology of coronary stent thrombosis (ST)]]===
 
===[[Predictors of coronary stent thrombosis]]===
 
===[[Treatment of coronary stent thrombosis]]===
 
===[[Prognosis of coronary stent thrombosis]]===
 
===[[Prevention of ST|Prevention of coronary stent thrombosis]]===
 
===[[Future Directions]]===
 
==Sources==
* Singh M Et al. Influence of coronary thrombus on outcome of percutaneous coronary angioplasty in the current  eta (the mayo clinc experince). Am J Cardiol 2001;88:1091-6
* White CJ et al. Coronary thrombi increase PTCA risk. Angioscopy as a clinicla tool. Circulation 1996;93:253-8
* G Sianos, et al. Angiographic stent thrombosis after routine use of drug eluting stents in ST -Segement elevation myocardial infarction, the importance of thrombus burden. JACC, Vol 50, No 7, 2007
* C. Spaulding, et al. Sirolimus-Eluting versus Uncoated Stents in acute myocardial infarction, N Engl J Med 2006;355:1093-104.
* Menichelli M . Sirolimus stent versus bare stent in acute myocardial infarction trail, Presented at European Percutaneou Cororanry Revascularizaton 2006.
 
 
==External links==
* [http://www.themdtv.org The MD TV: Comments on Hot Topics, State of the Art Presentations in Cardiovascular Medicine, Expert Reviews on Cardiovascular Research]
* [http://www.clinicaltrialresults.org Clinical Trial Results: An up to dated resource of Cardiovascular Research]
 
 
{{Electrocardiography}}
{{Circulatory system pathology}}
{{SIB}}


==[[Stent thrombosis prevention|Prevention]]==


[[Category:Cardiology]]
[[Category:Cardiology]]

Latest revision as of 16:09, 5 March 2013